Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain

Brain Research

Volumn 544, Issue 2, 1991, Pages 315-319

  McGeer, P L ^a   Walker, D G ^a   Akiyama, H ^a   Kawamata, T ^a   Guan, A L ^a   Parker, C J ^b   Okada, N ^c   McGeer, E G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer disease; CD59; Complement; Membrane attack complex; Membrane inhibitor of reactive lysis

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; COMPLEMENT FACTOR; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANTIGENS, CD59; ANTIGENS, DIFFERENTIATION; BRAIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; HUMAN; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEURONS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025779924     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(91)90071-3     Document Type: Article

References (20)

1. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
2. CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells
3. Complement activation in amyloid plaques in Alzheimer's dementia
4. Immunoglobulins and complement factors in senile plaques
5. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibit reactive lysis of the erythrocytes of paroxysmal noctural hemoglobinuria
6. Presence of immunoglobulins and complements in the amyloid plaques in the brain of patients with Alzheimer's disease
7. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
8. Immune system response in Alzheimer's disease
9. Reactive microglia in patients with senile dementia of the Alzheimer's type are positive for the histocompatibility glycoprotein HLA-DR
10. Anti-inflammatory drugs and Alzheimer's disease
11. Human protectin (CD59), and 18–20 kD homologous complement restriction factor, does not restrict perforin-mediated lysis
12. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo
13. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement
14. 20 kDa homologous restriction factor of complement resembles T cell activating protein
15. The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility
16. Immunological markers and neuropathological lesions in Alzheimer's disease
17. Expression of immune system-associated antigen by cells of the human central nervous system. Relationship to the pathology of Alzheimer's disease
18. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria
19. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer disease
20. Complement-activated oligodendroglia: a new pathogenetic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d